Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization.
Antimalarial drugs have usually been first deployed in areas of malaria endemicity at doses which were too low, particularly for high-risk groups such as young children and pregnant women. This may accelerate the emergence and spread of resistance, thereby shortening the useful life of the drug, but...
Автор: | White, N |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
2013
|
Схожі ресурси
Схожі ресурси
-
Use of population pharmacokinetic‐pharmacodynamic modelling to inform antimalarial dose optimization in infants
за авторством: Banda, CG, та інші
Опубліковано: (2024) -
Pharmacokinetics and pharmacodynamics of antimalarial drugs in pregnant women
за авторством: Kloprogge, F
Опубліковано: (2013) -
Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
за авторством: Tarning, J, та інші
Опубліковано: (2014) -
Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
за авторством: Tarning, J, та інші
Опубліковано: (2014) -
Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.
за авторством: White, N
Опубліковано: (1997)